1 Followers KLSE:0171 - Peterlabs Holdings Bhd Peterlabs Holdings Bhd
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance (Live Price)
Annual TTM
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2012 Q1 2012 Q2 2012 Q3 2012 Q4 2013 Q1 2013 Q2 2013 Q3 2013 Q4 2014 Q1 2014 Q2 2014 Q3 2014 Q4 2015 Q1 2015 Q2 2015 Q3 2015 Q4 2016 Q1 2016 Q2 2016 Q3 2016 Q4 2017 Q1 2017 Q2 2017 Q3 2017 Q4 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2019 Q1 2019 Q2 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 23.7M
4.4%
23.15M
-2.3%
24.41M
5.4%
24.31M
-0.4%
24.37M
0.2%
21.78M
-10.6%
19.13M
-12.2%
20.15M
5.3%
18.97M
-5.8%
48.96M
158.0%
46.37M
-5.3%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 19.35M
6.7%
19.27M
-0.4%
19.75M
2.5%
19.45M
-1.6%
19.8M
1.9%
17.72M
-10.5%
15.59M
-12.0%
16.31M
4.6%
15.2M
-6.8%
41.97M
176.1%
40.45M
-3.6%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 4.35M
-4.8%
3.88M
-10.7%
4.66M
19.9%
4.86M
4.5%
4.56M
-6.2%
4.06M
-11.1%
3.54M
-12.8%
3.84M
8.6%
3.77M
-1.8%
6.99M
85.2%
5.92M
-15.2%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 22.06M
4.9%
21.84M
-1.0%
23.06M
5.6%
22.68M
-1.7%
22.9M
1.0%
20.45M
-10.7%
18.38M
-10.1%
19.35M
5.3%
18.22M
-5.8%
46.84M
157.1%
45.11M
-3.7%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.71M
-6.4%
2.57M
-5.1%
3.31M
28.8%
3.23M
-2.3%
3.09M
-4.4%
2.74M
-11.6%
2.79M
2.0%
3.04M
9.1%
3.02M
-0.8%
4.87M
61.1%
4.66M
-4.3%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.64M
-1.9%
1.31M
-19.9%
1.34M
2.4%
1.63M
21.2%
1.47M
-9.8%
1.32M
-10.0%
746K
-43.6%
796K
6.7%
750.53K
-5.7%
2.12M
181.8%
1.26M
-40.4%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.43M
-5.7%
1.54M
7.6%
1.25M
-19.2%
1.42M
13.5%
1.5M
6.2%
1.32M
-12.0%
1.18M
-10.8%
1.79M
52.1%
1.14M
-36.2%
2.02M
76.9%
1.29M
-36.3%
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 999.53K
-1.3%
1M
0.3%
839K
-16.4%
1.14M
36.2%
1.29M
12.9%
911K
-29.4%
764K
-16.1%
1.23M
60.7%
985.34K
-19.8%
1.34M
35.9%
892K
-33.4%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 999.53K
-1.3%
1M
0.3%
839K
-16.4%
1.14M
36.2%
1.29M
12.9%
911K
-29.4%
764K
-16.1%
1.23M
60.7%
985.34K
-19.8%
1.34M
35.9%
892K
-33.4%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.005
0%
0.005
0%
0.004
-17.0%
0.005
35.9%
0.006
13.2%
0.004
-30.0%
0.004
-14.3%
0.005
52.8%
0.004
-23.6%
0.005
19.0%
0.003
-36%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.005
-1.0%
0.005
1.0%
0.004
-17.0%
0.005
35.9%
0.006
13.2%
0.004
-30.0%
0.004
-14.3%
0.005
52.8%
0.004
-23.6%
0.005
19.0%
0.003
-36%
Values are in MYR whenever applicable | Fiscal year ends on December 31
Powered by Morningstar